Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
The launch of the international campaign Pay As You Like
-
PHX Energy Services Corp. Announces Quarterly Dividend
-
Grace Therapeutics to Participate in the 2025 BIO International Conference
-
Tree Island Steel Announces Quarterly Dividend
-
June 2025 Letter to Shareholders of Nvni Group Limited
-
SharpLink Gaming Acquires 176,271 ETH for $463 Million, Officially Becoming Largest Publicly-Traded ETH Holder
-
Taseko Annual General Meeting Voting Results
-
Co-Founder of MidCap Howard Widra to Retire at the End of 2026
-
180 Degree Capital Corp. Notes Filing of Updated Preliminary Joint Proxy Statement/Prospectus for Proposed Business Combination With Mount Logan Capital Inc.
-
ESGL Shareholders Approve All Proposals for Business Combination with De Tomaso Automobili
-
Bitcoin Depot Adds to Bitcoin Treasury Holdings Amid Continued Market Momentum
-
Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025
-
Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants
-
Horizon Aircraft Partners with MT-Propeller for Hybrid eVTOL Propulsion
-
Panavance Therapeutics Announces Promising Misetionamide (GP-2250) Phase 1 Clinical Trial Interim Findings in Pancreatic Cancer at BIO 2025
-
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025
-
Composition of Kalmar Corporation’s Shareholders’ Nomination Board
-
JBDI Holdings Announces Results of Annual General Meeting
-
Kaldvík AS: Notice of Annual General Meeting
-
Official Announcement: Legal Statement on Trademark and App Name by RBH
-
BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
-
Phillips Edison & Company Announces Pricing of Offering of $350 Million Aggregate Principal Amount of 5.250% Senior Unsecured Notes Due 2032
-
Phillips Edison & Company Announces Pricing of Offering of $350 Million Aggregate Principal Amount of 5.250% Senior Unsecured Notes Due 2032
-
New Wave Announces Investment in Cartwheel Robotics, an Advanced Robotics Company Seeking to Build Humanoids for Humans
-
Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions
-
Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split
-
Chart Industries to Present at J.P. Morgan Energy, Power, Renewables & Mining Conference
-
Peyto Exploration & Development Corp. Announces Retirement of a Director and Confirms Monthly Dividend for July 15, 2025
-
Advanced Flower Capital Announces Dividend for the Second Quarter 2025
-
reAlpha Expands Homebuying Platform into Texas, Marking First Step in National Realty Rollout
-
Sunrise Realty Trust Announces Dividend for the Second Quarter 2025
-
Senmiao Technology Signs a Strategic Cooperation Agreement with Changsha Yipeng to Develop an AI-Backed Data Management System for Online Ride-Hailing Service Providers
-
Chart Industries to Present at J.P. Morgan Energy, Power, Renewables & Mining Conference
-
Form 8.3 - Marlowe plc - Octopus Investments
-
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
-
Melco Announces Appointment of New Independent Non-Executive Director
-
Form 8.3 - [ALPHA GROUP INTERNATIONAL PLC - 12 06 2025] - (CGAML)
-
Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress
-
NexGold Infill Drilling Intersects 25.79 g/t Gold Over 4.5 Metres and 18.09 g/t Gold over 3.0 Metres at the Goldboro Gold Project
-
Mint Tools Announces Launch of S-Waver, Bringing Salon-Quality Beach Waves to Home Styling
-
AYR Provides Update on Delay of Q1 2025 Interim Financial Filings
-
Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors
-
ORLADEYO® (berotralstat) Approved in Colombia
-
Fractyl Health to Present New Preclinical Data from its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association's 85th Scientific Sessions
-
MoneyHero Group Reports First Quarter 2025 Results
-
Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds
-
Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Supporting Differentiated Profile in Sickle Cell Disease (SCD) at European Hematology Association (EHA) 2025 Cong
-
Fractyl Health to Present New Preclinical Data from its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association's 85th Scientific Sessions
-
Baker Hughes Announces Dates for Second-quarter Earnings Release and Webcast
